SON is an essential m6A target for hematopoietic stem cell fate.
| Publication Type | Academic Article |
| Authors | Luo H, Cortés-López M, Tam C, Xiao M, Wakiro I, Chu K, Pierson A, Chan M, Chang K, Yang X, Fecko D, Han G, Ahn E, Morris Q, Landau D, Kharas M |
| Journal | Cell Stem Cell |
| Volume | 30 |
| Issue | 12 |
| Pagination | 1658-1673.e10 |
| Date Published | 12/07/2023 |
| ISSN | 1875-9777 |
| Keywords | Hematopoietic Stem Cells, Inflammation, DNA-Binding Proteins, RNA Methylation |
| Abstract | Stem cells regulate their self-renewal and differentiation fate outcomes through both symmetric and asymmetric divisions. m6A RNA methylation controls symmetric commitment and inflammation of hematopoietic stem cells (HSCs) through unknown mechanisms. Here, we demonstrate that the nuclear speckle protein SON is an essential m6A target required for murine HSC self-renewal, symmetric commitment, and inflammation control. Global profiling of m6A identified that m6A mRNA methylation of Son increases during HSC commitment. Upon m6A depletion, Son mRNA increases, but its protein is depleted. Reintroduction of SON rescues defects in HSC symmetric commitment divisions and engraftment. Conversely, Son deletion results in a loss of HSC fitness, while overexpression of SON improves mouse and human HSC engraftment potential by increasing quiescence. Mechanistically, we found that SON rescues MYC and suppresses the METTL3-HSC inflammatory gene expression program, including CCL5, through transcriptional regulation. Thus, our findings define a m6A-SON-CCL5 axis that controls inflammation and HSC fate. |
| DOI | 10.1016/j.stem.2023.11.006 |
| PubMed ID | 38065069 |
| PubMed Central ID | PMC10752439 |